Prosthetic joint infection (PJI; infected hip/knee arthroplasty)
Painful/loosening prosthesis +/- sinus; get cultures, no blind abx; surgery decides cure · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Infection of a joint prosthesis, biofilm-mediated and difficult to eradicate. Early (<3 months), delayed (3-12 months, low-virulence e.g. coagulase-negative staph, Cutibacterium) or late haematogenous. Diagnosis rests on joint aspirate and multiple operative cultures; cure needs combined surgery (DAIR, one- or two-stage revision) plus prolonged culture-directed antibiotics.
Red flags
- Systemic sepsis from an infected prosthesis
- Discharging sinus over prosthesis (diagnostic of PJI)
- Acute haematogenous PJI with another infective source (e.g. S. aureus bacteraemia, endocarditis)
- Rapid implant loosening / instability
Assessment
Differential diagnosis
- Aseptic loosening
- Crystal arthropathy / inflammatory flare
- Periprosthetic fracture
- Adjacent cellulitis / bursitis
- Referred pain
Investigations
- CRP/ESR (raised supports but normal doesn't exclude), FBC
- Joint aspiration BEFORE antibiotics: synovial WCC/differential, Gram stain, culture, +/- alpha-defensin/leukocyte esterase
- Blood cultures if febrile/haematogenous
- Plain X-ray (loosening, lucency); further imaging as directed
- At revision: >=3-5 deep tissue/periprosthetic cultures + histology; sonication of explanted prosthesis increases yield
- Identify source in late haematogenous PJI (skin, urine, dental, endocarditis)
Management
- Do NOT give blind antibiotics to a stable patient - withhold until adequate cultures obtained (unless septic/unstable)
- Refer urgently to the arthroplasty/bone-and-joint infection MDT
- Surgical strategy drives cure: DAIR (debridement, antibiotics, implant retention) for acute/early with stable implant; one- or two-stage revision for chronic
- Culture-directed prolonged antibiotics, typically IV then oral, often with rifampicin for staphylococcal biofilm (if retained/partially retained implant)
- Treat any remote source; optimise comorbidities, nutrition, glycaemia
- If septic from PJI, resuscitate and give empirical broad cover per local policy after cultures
Drugs & doses
Empirical only if septic (after cultures): vancomycin IV + a broad Gram-negative agent (e.g. piperacillin-tazobactam 4.5 g IV QDS) per local policy
Staphylococcal (MSSA): flucloxacillin 2 g IV QDS or cefazolin; (MRSA/CoNS): vancomycin or daptomycin 8-10 mg/kg IV OD or teicoplanin
Add rifampicin 300-450 mg PO BD for staphylococcal biofilm when implant retained/DAIR - NEVER as monotherapy (resistance) [verify local dose]
Oral step-down (biofilm-active combos): rifampicin + a fluoroquinolone (e.g. ciprofloxacin/levofloxacin) for susceptible staph; otherwise culture-directed (clindamycin, co-trimoxazole, linezolid, doxycycline)
Cutibacterium (shoulder): benzylpenicillin/amoxicillin or ceftriaxone, long course
Total duration commonly 6-12 weeks (regimen/surgery dependent) [verify local]
Disposition
Admit / refer to the specialist bone-and-joint infection MDT. Emergency management if septic. Prolonged antibiotics via OPAT with surgical and ID follow-up.
Complications & pitfalls
- Chronic infection, treatment failure, recurrence
- Need for staged/multiple revisions, arthrodesis, amputation
- Sepsis, metastatic infection
- Functional loss, chronic antibiotic suppression
Exam pearls
- A sinus communicating with the prosthesis is diagnostic - no further proof needed
- Blind antibiotics sabotage culture yield and cure - sample first unless the patient is septic
- Rifampicin for retained-implant staphylococcal PJI only in combination - monotherapy breeds resistance
- Low-virulence organisms (CoNS, Cutibacterium) cause indolent delayed PJI - take multiple deep cultures and hold them long
- Sonication of the explant markedly improves microbiological yield
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.